MedTrace Logo

Strength Training and Eating Disorders

NCT06809244 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-02-05

No results posted yet for this study

Summary

The aim of this pilot study is to test feasibility of assessment methods and immediate responses to two different strength training sessions, maximal strength training and hypertrophy strength training, among persons undergoing treatment for eating disorders. The study will combine quantitative methods to assess immediate physiological and affective responses to two adapted and supervised strength training sessions. Following the sessions, qualitative in-dept interviews will address the participants' experiences with the strength training sessions. A total of 30 participants from different treatment settings for eating disorders will be recruited to participation. Assessments include symptoms of eating disorders, muscle strength, physical activity behaviour and motivation, blood pressure, heart rate variability, body temperature, lactate, percievied exertion and affective responses. The findings of the study will be utilized in a randomized clinical trial with strength training as part of treatment for eating disorders.

Conditions

Interventions

OTHER

Exercise

Strength training as described under "arm"

Sponsors & Collaborators

  • Modum Bad

    collaborator OTHER

  • Lovisenberg Diakonale Hospital

    collaborator OTHER

  • University of South-Eastern Norway

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-01
Primary Completion
2026-10-31
Completion
2027-01-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06809244 on ClinicalTrials.gov